Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2002
08/28/2002CN1365801A Nano medicine 'Shenrong Guben' and its preparing process
08/28/2002CN1365797A Nano medicine 'Xiaoerkang' and its preparing process
08/28/2002CN1365795A Nano medicine for treating infantile diarrhea and its preparing process
08/28/2002CN1365794A Nano medicine 'Xingnaojing' and its preparing process
08/28/2002CN1365792A Nano medicine 'Yangchun' and its preparing process
08/28/2002CN1365789A Nano medicine 'Baolong' and its preparing process
08/28/2002CN1365788A Nano medicine 'Baochi' and its preparing process
08/28/2002CN1365786A Nano medicine 'Anwei' and its preparing process
08/28/2002CN1365785A Nano medicine 'Anshen Buxin' and its preparing process
08/28/2002CN1365780A Nano medicine 'Qingguo' and its preparing process
08/28/2002CN1365779A Nano medicine 'Qinge' and its preparing process
08/28/2002CN1365777A Nano medicine 'Qipi' and its preparing process
08/28/2002CN1365776A Nano medicine 'Pinggan Shuluo' and its preparing process
08/28/2002CN1365774A Nano medicine 'Niuhuang Shangqing' and its preparing process
08/28/2002CN1365768A Nano 6-component Anxiao medicine and its preparing process
08/28/2002CN1365766A Nano medicine 'Wuji' and its preparing process
08/28/2002CN1365765A Nano medicine 'Zhuangyuan' and its preparing process
08/28/2002CN1365764A Nano medicine for treating toothache and its preparing process
08/28/2002CN1365763A Nano 6-component Muxiao medicine and its preparing process
08/28/2002CN1365761A Nano medicine 'Zhuche' and its preparing process
08/28/2002CN1365749A Nano medicine 'Xiongju Shangqing' and its preparing process
08/28/2002CN1365747A Nano medicine 'Wubei' and its preparing process
08/28/2002CN1365746A Nano medicine 'Sizheng' and its preparing process
08/28/2002CN1365741A Nano medicine 'Kaixiong Liqi' and its preparing process
08/28/2002CN1365737A Nano medicine 'Jiawei Guiqi' and its preparing process
08/28/2002CN1365725A Nano medicine 'Gengyi' and its preparing process
08/28/2002CN1365723A Nano compound medicine for treating hepatopathy and its preparing process
08/28/2002CN1365721A Nano medicine 'Erzhi' and its preparing process
08/28/2002CN1365718A Nano medicine 'Huangdan Yinchen' for treating icterus and its preparing process
08/28/2002CN1365717A Nano medicine 'Jianer Xiaoshi' and its preparing process
08/28/2002CN1365713A Nano medicine for treating ulcer and its preparing process
08/28/2002CN1365712A Nano coptis medicine and its preparing process
08/28/2002CN1365709A Nano medicine for child to relieve cough and its preparing process
08/28/2002CN1365708A Nano medicine for treating infantile diarrhea and its preparing process
08/28/2002CN1365707A Nano medicine for treating infantile hepatitis and its preparing process
08/28/2002CN1365705A Nano medicine 'Xiaoer Huadu' and its preparing process
08/28/2002CN1365704A Nano medicine 'Xiaoer Huashi' and its preparing process
08/28/2002CN1365701A Nano 25-component tophus medicine and its preparing process
08/28/2002CN1365699A Nano health-medicine for tonifying kidney and its preparing process
08/28/2002CN1365698A Nano medicine 'Muxiang Fenqi' and its preparing process
08/28/2002CN1365697A Nano medicine 'Naoling' and its preparing process
08/28/2002CN1365690A Nano ganoderma medicine and its preparing process
08/28/2002CN1365687A Nano medicine 'Erkangning' and its preparing process
08/28/2002CN1365686A Nano clove medicine and its preparing process
08/28/2002CN1365684A Nano haw medicine and its preparing process
08/28/2002CN1365683A Nano medicine 'Dahuang Qingwei' and its preparing process
08/28/2002CN1365682A Nano rhubarb medicine and its preparing process
08/28/2002CN1365681A Nano medicine 'Awei Huapi' and its preparing process
08/28/2002CN1365679A Nano medicine 'Anyang' and its preparing process
08/28/2002CN1365676A Nano medicine 'Compound berberine' and its preparing process
08/28/2002CN1365675A Nano medicine 'Fuzilizhong' and its preparing process
08/28/2002CN1365672A Nano medicine for treating baby obesity and its preparing process
08/28/2002CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
08/28/2002CN1089759C Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
08/28/2002CN1089604C Gastroenteritic disease treating medicine and its preparation
08/28/2002CN1089595C Chinese medicine for treating toothache
08/28/2002CN1089593C Chinese medicinal preparation for treatment of toothache and method for preparation thereof
08/28/2002CN1089591C Medical power or capsule for treating gastropathies
08/28/2002CN1089590C Capsule for warming-up stomach and reinforcing function of heart, spleen or kidney
08/28/2002CN1089589C Laryngeal bactericidal and antiseptic composition
08/27/2002US6441153 Human carboxypeptidases and polynucleotides encoding the same
08/27/2002US6441036 Treating atherosclerosis and insulin resistance
08/27/2002US6441032 Treating systemic lupis and multiple sclerosis
08/27/2002US6441012 Chemical compounds
08/27/2002US6441004 Monocyte chemoattractant protein-1 inhibitor compounds
08/27/2002US6441000 Compounds useful in therapy
08/27/2002US6440997 −E-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethylpiperidine, and its antidiarrhoeal use
08/27/2002US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
08/27/2002US6440962 Cardiovascular disorders, antiischemic agents
08/27/2002US6440959 Inhibitors of cyclin-dependent kinases
08/27/2002US6440955 Anti-inflammatory agents
08/27/2002US6440953 Use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion.
08/27/2002US6440937 Competitive inhibitors of trypsin-like serin proteases, especially thrombin and kininogenases such as kallikrein; thrombin inhibitors, anticoagulants, and antiinflammatory agents
08/27/2002US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy
08/27/2002US6440413 Selectively destroying subunit a without destroying subunit b of cholera toxin; enzyme with preponderance of exocellular proteinase produced by a culture of streptomyces fradiae; hyperviscosity of intestinal, bronchial and/or genital mucus
08/22/2002WO2002064792A2 Molecules for disease detection and treatment
08/22/2002WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/22/2002WO2002064714A1 PRODUCTS CONTAINING $G(b)-GLUCAN
08/22/2002WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89)
08/22/2002WO2002064626A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
08/22/2002WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors
08/22/2002WO2002064599A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
08/22/2002WO2002064595A1 Triazolo compounds as mmp inhibitors
08/22/2002WO2002064594A2 6-substituted pyrido-pyrimidines
08/22/2002WO2002064592A1 Tricyclic crf receptor antagonists
08/22/2002WO2002064591A2 Carboline derivatives
08/22/2002WO2002064590A2 Carboline derivatives
08/22/2002WO2002064589A1 Laulimalide derivatives
08/22/2002WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof
08/22/2002WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors
08/22/2002WO2002064580A1 Lactone compounds as novel photoinitiators
08/22/2002WO2002064578A1 Benzo thiadiazine matrix metalloproteinase inhibitors
08/22/2002WO2002064572A1 Quinazolines as mmp-13 inhibitors
08/22/2002WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
08/22/2002WO2002064564A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor
08/22/2002WO2002064552A1 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
08/22/2002WO2002064547A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002064169A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases